COVINGTON, La.--(BUSINESS WIRE)--Globalstar (NASDAQ: GSAT), a next-generation telecommunications infrastructure and technology provider, announces its continued partnership of delivering critical global connectivity for the agricultural technology solutions developed by CERES TAG, the world's leading animal health intelligence platform, as it prepares its readiness in the event of an outbreak of the New World Screwworm. As the livestock industry in Mexico grapples with the recent outbreak of th.

Capricor Therapeutics said on Tuesday the U.S. Food and Drug Administration will not convene its panel of outside experts before deciding on the company's cell therapy for a heart condition associated with Duchenne muscular dystrophy.

As Bitcoin rebounds past $105K after a ceasefire, CME, ACN, V and PYPL emerge as crypto-centric stocks with upside potential.

Flotek Industries' recurring-revenue pivot and global expansion outshine Prairie Operating's drilling push in energy.

Tesla Inc.'s (NASDAQ: TSLA) first test of the robotaxi on the open road has started in Austin.

LOS ANGELES , June 24, 2025 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP) ("Cadiz," the "Company"), a California water solutions company, announced today that the Company will participate in the 15th Annual ROTH London Conference being held at the Four Seasons Hotel London at Park Lane in London, UK on June 25-26, 2025. Cadiz's Chairman and CEO Susan Kennedy will be participating in one-on-one meetings throughout the conference with institutional investors.

Moderated discussion with founding physician of the Brain Tumor Center and Director of Neuro-Oncology at Piedmont Atlanta Hospital, Dr. Erin Dunbar HOUSTON, TX / ACCESS Newswire / June 24, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the release of a Virtual Investor KOL Connect segment featuring Dr. Erin Dunbar, a founding physician of the Brain Tumor Center and Director of Neuro-Oncology at Piedmont Atlanta Hospital, who specializes in the comprehensive care of brain …

Company also announces certain corporate actions ROUND ROCK, TX / ACCESS Newswire / June 24, 2025 / AYRO, Inc. (NASDAQ:AYRO) ("AYRO" or the "Company"), today announces that it is exploring a range of strategic alternatives to enhance stockholder value, including digital asset initiatives, with a focus on the underlying technology of crypto-based stablecoins, and operational initiatives to grow its core business. As part of this process, the Company is actively exploring new market opportunities that leverage its existing assets and balance sheet.

SANTA CLARA, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and automation, today announced a strategic R&D collaboration with Fraunhofer Institute for Silicon Technology (ISIT). The partnership aims to accelerate development of next-generation Gallium Nitride (GaN) devices using Silvaco's industry-leading Power Devices Solution to perform Design Technology Co-Optimization (DTCO). This collaboration aligns with Fraunhofer ISIT's role in the EU Chips Act initiative through its participation in the APECS pilot line (www.apecs.eu).

NEW YORK--(BUSINESS WIRE)---- $TNFA--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that it has formed a philanthropic collaboration with the DADA2 Foundation, a nonprofit organization seeking innovative ways to accelerate research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). Together, the parties are expected.

Strategic capital deployment into TAO advances Synaptogenix's blockchain treasury model, leveraging BitGo's custody, trading and staking capabilities to generate token-based yield NEW YORK , June 24, 2025 /PRNewswire/ -- Synaptogenix (NASDAQ: SNPX) today announced its initial purchase of TAO as part of the Company's recently announced cryptocurrency treasury strategy focused exclusively on artificial intelligence (Al) and machine learning. BitGo, the leading infrastructure provider of digital asset solutions, has been selected to provide qualified custody, staking and trading services for Synaptogenix's TAO holdings.

MIAMI , June 24, 2025 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) announced financial results for the second quarter 2025 and provided an updated outlook for the full year and an outlook for the third quarter 2025. Exceeded 2026 SEA Change financial targets 18 months early, with adjusted return on invested capital ("ROIC")1,2 and adjusted EBITDA per available lower berth day ("ALBD")1,2 reaching the highest levels in nearly two decades.

WEST PALM BEACH, FL and VANCOUVER, BC, June 24, 2025 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“AgriFORCE” or the “Company”) (NASDAQ: AGRI) today announced a transformative tri-pillar growth strategy aimed at capitalizing on the accelerating global demand for computational power. This strategic framework focuses on three key areas: Bitcoin treasury development, modular compute infrastructure, and integration with scalable, off-grid energy systems.

HOUSTON, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Houston American Energy Corp. (NYSE American: HUSA) (the “Company”) today announced that it has entered into a definitive agreement with an institutional investor (the “SPA”) for the purchase and sale of an aggregate of 81,629 shares of common stock at a purchase price of $14.80 per share in a registered direct offering (the “Offering”).

- Near doubling of 1-year overall survival (OS), increased median OS of 4 months (12.5 vs 8.5 months), and 43% reduction in risk of death in patients treated with at least one cycle (4 weeks) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) vs GnP alone

GULFPORT, Miss.--(BUSINESS WIRE)--Hancock Whitney Corporation to Announce Second Quarter 2025 Financial Results and Host Conference Call July 15.

Tom White demonstrates a bullish call diagonal trade strategy ahead of FedEx (FDX) earnings. He walks through the technical setup ahead of the earnings event, pointing to the stock's 50-day simple moving average and its momentum RSI study as key indicators to track.

With the stock market recovery in full swing, investors may be wondering if it's time to get back in the higher-yielding dividend plays that are still well off their all-time highs as a “catch-up” trade of sorts.

Warren Buffett is well known for favoring companies with a strong dividend track record.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.